2015
DOI: 10.1080/23723556.2015.1014219
|View full text |Cite
|
Sign up to set email alerts
|

Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
(9 reference statements)
0
2
0
Order By: Relevance
“…Importantly, in the study, the lack of p62 had little effect on the lifespan and function of normal HSPCs. This suggested that disturbing p62/TRAF6 binding may hold promise for treating miR-146a-deficient leukemia 127 .…”
Section: Autophagy-related Proteins Affect Human Disease By Regulatin...mentioning
confidence: 99%
“…Importantly, in the study, the lack of p62 had little effect on the lifespan and function of normal HSPCs. This suggested that disturbing p62/TRAF6 binding may hold promise for treating miR-146a-deficient leukemia 127 .…”
Section: Autophagy-related Proteins Affect Human Disease By Regulatin...mentioning
confidence: 99%
“…In multiple myeloma cells treated with TNF-α, high-risk myelodysplastic syndromes/acute myeloid leukemia (AML) del(5q) cells and hematopoietic stem cells/progenitor cells with miR-146a deletion, the sustained expression of SQSTM1/p62 has an oncogenic effect that leads to the marked activation of NF-κB or p38 MAPK cascades through the following mechanisms: i) Direct binding to and ubiquitination of TRAF-6 through its TRAF-binding domain to activate the NF-κB signaling pathway (63)(64)(65); ii) direct binding with receptor-interacting protein 1 through its C-terminal region ZZ domain, as well as with atypical PKCs through its N-terminal PB1 domain to activate the NF-κB signaling pathway (66,67); and iii) direct binding to p38 MAPK through its p38 domain to activate the p38 MAPK signaling pathway (68). Activated NF-κB can further enhance SQSTM1/p62 gene expression, ultimately generating predominately positive feedback loops to continuously amplify its deleterious effect in exacerbating unrestrained growth, proliferation and malignant transformation, and inhibiting osteoblast activation to hamper bone formation (66,69).…”
Section: Hematological Malignancymentioning
confidence: 99%